BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Singapore
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:+08
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260209T140000
DTEND;TZID=Europe/Paris:20260209T150000
DTSTAMP:20260405T091654
CREATED:20260126T010719Z
LAST-MODIFIED:20260126T010728Z
UID:10000623-1770645600-1770649200@oncodaily.com
SUMMARY:Pregnancy-Associated Cancer: Clinical Challenges and Ethical Insights
DESCRIPTION:The ESMO Young Oncologists Committee (YOC) will host the next session of the YO4YO Virtual Session Series on Monday\, February 9\, 2026\, from 14:00 to 15:00 CET. This interactive Clinical Case Discussion\, titled “Pregnancy-associated cancer: Clinical challenges and ethical insights\,” is designed to provide young oncologists with a platform to engage with experts on complex clinical scenarios and their associated ethical dilemmas. \nThe session features a distinguished panel\, including Guilherme Nader Marta as the YOC Coordinator\, alongside experts Ann Partridge and Matteo Lambertini\, who will lead the dialogue and offer practical guidance for managing these challenging cases. These virtual sessions aim to foster international collaboration and networking among early-career oncology professionals while addressing specific professional and scientific development needs. \nJoin the session.
URL:https://oncodaily.com/event/pregnancy-associated-cancer-447025
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-6.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:https://esmo-org.zoom.us/j/87294357860?pwd=IHPJamhrV2Ukauh0paWbNjgPrNFKJe.1#success
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260206
DTEND;VALUE=DATE:20260209
DTSTAMP:20260405T091654
CREATED:20251102T222927Z
LAST-MODIFIED:20251102T222940Z
UID:10000311-1770336000-1770595199@oncodaily.com
SUMMARY:ESMO Summit Africa 2026
DESCRIPTION:The ESMO Summit Africa 2026 is a three-day educational event focused on delivering a summary and contextual review of the most significant cancer treatment advances presented at the previous ESMO annual Congress\, tailored specifically for the oncology community in Africa. Scheduled to take place in Cape Town\, South Africa\, from 6 to 8 February 2026\, the Summit’s main objectives are to review the current standard of care for key malignancies from both a local and international perspective and to discuss current controversies in cancer management. \nYou can find more posts featuring ESMO on OncoDaily.
URL:https://oncodaily.com/event/esmo-summit-africa-402240
LOCATION:Century City Conference Centre\, 4 Energy Lane\, Century City\, Cape Town\, Western Cape\, 7446\, South Africa
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/11/ESMO-Africa.png
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260205
DTEND;VALUE=DATE:20260207
DTSTAMP:20260405T091654
CREATED:20251126T001629Z
LAST-MODIFIED:20251126T001641Z
UID:10000402-1770249600-1770422399@oncodaily.com
SUMMARY:ESMO Preceptorship on Cervical Cancer 2026: Cape Town
DESCRIPTION:The ESMO Preceptorship on Cervical Cancer 2026: Cape Town is a two-day educational course focusing on providing oncologists with a thorough understanding of cervical cancer management\, including screening\, prevention\, diagnosis\, and the standard of care for early\, locally advanced\, recurrent\, and metastatic disease. The event is scheduled for February 5–6\, 2026\, in Cape Town\, South Africa\, and is accredited with ESMO-MORA category 1 points.
URL:https://oncodaily.com/event/esmo-preceptorship-416466
LOCATION:Cape Town\, South Africa
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/ESMO-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260204
DTEND;VALUE=DATE:20260205
DTSTAMP:20260405T091654
CREATED:20251227T144458Z
LAST-MODIFIED:20251227T144507Z
UID:10000536-1770163200-1770249599@oncodaily.com
SUMMARY:ESMO Deep Dive: Genitourinary cancers: Multimodal Therapy in MIBC: From Established Standard to Future Directions 2026
DESCRIPTION:The ESMO Deep Dive: Genitourinary Cancers: Multimodal Therapy in MIBC: From Established Standard to Future Directions 2026 is a technical scientific webinar focused on the evolving treatment landscape of muscle-invasive bladder cancer (MIBC). Scheduled for February 4\, 2026\, this virtual symposium addresses the clinical challenges of MIBC\, which is characterized by high morbidity and mortality. \nOrganized by the European Society for Medical Oncology (ESMO) and chaired by Viktor Gruenwald\, the webinar aims to equip oncology professionals with the skills to critically evaluate emerging data and personalize therapeutic approaches\, including bladder-sparing modalities and biomarker-enabled precision medicine. \nRegister.
URL:https://oncodaily.com/event/esmo-deep-dive-434701
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-on-Air-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260131
DTEND;VALUE=DATE:20260201
DTSTAMP:20260405T091654
CREATED:20251227T143844Z
LAST-MODIFIED:20251227T143852Z
UID:10000535-1769817600-1769903999@oncodaily.com
SUMMARY:ESMO in Focus Immuno-Oncology Bulgaria 2026
DESCRIPTION:The ESMO in Focus Immuno-Oncology Bulgaria 2026 is a licensed scientific conference organized by the Bulgarian Scientific Society for Immuno-Oncology (BSIO) in collaboration with the European Society for Medical Oncology (ESMO). \nScheduled for January 31\, 2026\, in Sofia\, the meeting serves as a regional forum to disseminate the latest clinical data and therapeutic breakthroughs presented at the ESMO Immuno-Oncology Congress 2025 held in London. The technical program focuses on the evolution of personalized immunotherapy\, emerging biomarkers for checkpoint inhibitor response\, and the clinical management of immune-related adverse events across various solid tumors. \nRegister.
URL:https://oncodaily.com/event/esmo-in-focus-434690
LOCATION:InterContinental Sofia\, 4 Narodno Sabranie Square\, Sofia\, Sofia City\, 1000\, Bulgaria
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-Bulgaria.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260128
DTEND;VALUE=DATE:20260129
DTSTAMP:20260405T091654
CREATED:20251126T001040Z
LAST-MODIFIED:20251126T001052Z
UID:10000401-1769558400-1769644799@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases - Webinar Series: Colorectal Cancer 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases – Webinar Series: Colorectal Cancer 2026 is a live virtual event focused on discussing real-world clinical cases and applying ESMO guidelines to the management of colorectal cancer. This webinar is scheduled to take place virtually on January 28\, 2026\, at 18:30 CET (Central European Time). \nRegister.
URL:https://oncodaily.com/event/real-world-cases-416464
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/esmo.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260124
DTEND;VALUE=DATE:20260125
DTSTAMP:20260405T091654
CREATED:20251227T142759Z
LAST-MODIFIED:20251227T142830Z
UID:10000534-1769212800-1769299199@oncodaily.com
SUMMARY:ESMO Advanced Course on CDK4/6 Inhibitors in Breast Cancer Management 2026: Jeddah
DESCRIPTION:The ESMO Advanced Course on CDK4/6 Inhibitors in Breast Cancer Management 2026 is an intensive\, single-day educational symposium scheduled for January 24\, 2026\, in Jeddah\, Saudi Arabia. \nOrganized by the European Society for Medical Oncology (ESMO)\, this event is designed as a closed course specifically for invited medical oncologists and oncology fellows from the Middle East. The program focuses on the biological function of CDK4/6 in breast cancer and the practical integration of CDK4/6 inhibitors into the treatment landscape for both early-stage and metastatic hormone receptor-positive (HR+) / HER2-negative breast cancer.
URL:https://oncodaily.com/event/breast-cancer-management-434682
LOCATION:Jeddah\, Saudi Arabia
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-2.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260121
DTEND;VALUE=DATE:20260122
DTSTAMP:20260405T091654
CREATED:20260120T144735Z
LAST-MODIFIED:20260120T144743Z
UID:10000602-1768953600-1769039999@oncodaily.com
SUMMARY:ESMO Therapeutic Landscapes: Toxicity of Cellular Therapies 2026
DESCRIPTION:The ESMO webinar “Therapeutic Landscapes: Toxicity of Cellular Therapies 2026“ is a specialized virtual educational session scheduled for January 21\, 2026\, at 18:30 CET. \nLed by chairs and speakers Claire Roddie\, Marco Donia\, and Changsong Qi\, the program focuses on the recognition and management of unique complications arising from advanced cancer treatments\, specifically CAR-T and TIL-based adoptive cell therapies. Key topics include the clinical presentation of cytokine release syndrome (CRS)\, immune effector cell-associated neurotoxicity syndrome (ICANS)\, and emerging toxicities associated with tumor-infiltrating lymphocytes. \nRegister.
URL:https://oncodaily.com/event/toxicity-of-cellular-therapies-444070
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260116
DTEND;VALUE=DATE:20260118
DTSTAMP:20260405T091654
CREATED:20251124T213453Z
LAST-MODIFIED:20251124T213510Z
UID:10000400-1768521600-1768694399@oncodaily.com
SUMMARY:ESMO Preceptorship on Breast Cancer 2026: Milan
DESCRIPTION:The ESMO Preceptorship on Breast Cancer 2026: Milan is a two-day educational course that provides oncologists with a thorough understanding of breast cancer management\, covering topics from diagnosis to treatment\, based on current standards of care in a multidisciplinary setting. \nThe preceptorship will take place from January 16–17\, 2026\, in Milan\, Italy. The course is accredited with ESMO-MORA category 1 points\, and the application deadline for attendance is November 25\, 2025. \nApply.
URL:https://oncodaily.com/event/preceptorship-on-breast-cancer-415828
LOCATION:Milan\, Italy
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/16_9-2.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251216
DTEND;VALUE=DATE:20251218
DTSTAMP:20260405T091654
CREATED:20251124T213007Z
LAST-MODIFIED:20251124T213103Z
UID:10000399-1765843200-1766015999@oncodaily.com
SUMMARY:ESMO Preceptorship on Prostate Cancer 2025: Lugano
DESCRIPTION:The ESMO Preceptorship on Prostate Cancer 2025: Lugano is a two-day educational course focusing on a thorough understanding of prostate cancer management\, from diagnosis to treatment\, according to current standards of care. \nOrganized by the European Society for Medical Oncology (ESMO)\, the event is scheduled to take place on December 16–17\, 2025\, in Lugano\, Switzerland. The preceptorship is designed primarily for medical and clinical oncologists\, especially young oncologists\, and has been accredited for 9 ESMO-MORA category 1 points.
URL:https://oncodaily.com/event/preceptorship-on-prostate-cancer-415823
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/09/1756803627507.jpeg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251213
DTEND;VALUE=DATE:20251215
DTSTAMP:20260405T091654
CREATED:20251124T212249Z
LAST-MODIFIED:20251124T212304Z
UID:10000398-1765584000-1765756799@oncodaily.com
SUMMARY:Best of ESMO India 2025
DESCRIPTION:The Best of ESMO India 2025 is an ESMO-licensed event making its Indian debut in Mumbai\, scheduled for December 13–14\, 2025. \nThis conference\, hosted by the Global Healthcare Academy (GHA)\, is a major platform for disseminating the most recent\, cutting-edge data and clinical practices from the main European Society for Medical Oncology (ESMO) Congress. \nDesigned for a multidisciplinary audience including medical\, surgical\, and radiation oncologists\, the event will feature focus sessions guided by an extensive advisory\, core\, and scientific committee comprising leading Indian oncologists\, and will be held at The St. Regis Mumbai. \nRegister.
URL:https://oncodaily.com/event/best-of-esmo-india-415818
LOCATION:The St. Regis Mumbai\, 462 Senapati Bapat Marg\, Lower Parel\, Mumbai\, Maharashtra\, 400013\, India
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/16_9-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20251210T083000
DTEND;TZID=America/Halifax:20251210T120000
DTSTAMP:20260405T091654
CREATED:20251206T001840Z
LAST-MODIFIED:20251206T001927Z
UID:10000455-1765355400-1765368000@oncodaily.com
SUMMARY:ESMO-IO SITC Primer Program
DESCRIPTION:The ESMO-IO SITC Primer Program is a joint educational event organized by the European Society for Medical Oncology (ESMO) and the Society for Immunotherapy of Cancer (SITC)\, scheduled for December 10\, 2025\, from 8:30 a.m. to 12:00 p.m. BST. \nThis half-day primer\, held at the Queen Elizabeth II Centre in London\, UK\, focuses on fundamental immuno-oncology (IO) concepts. \nThe program will cover current and emerging topics in immuno-oncology (IO)\, including neoadjuvant immunotherapy\, intratumoral immunotherapies\, recombinant cytokines\, and bispecific antibodies\, alongside new applications of AI\, spatial biology\, and multiomic approaches.
URL:https://oncodaily.com/event/esmo-422513
LOCATION:Queen Elizabeth II Centre in London\, United Kingdom\, Broad Sanctuary\, London SW1P 3EE\, London\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMOSITC.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251210T080000
DTEND;TZID=Europe/London:20251212T170000
DTSTAMP:20260405T091654
CREATED:20250701T130014Z
LAST-MODIFIED:20250701T130110Z
UID:10000206-1765353600-1765558800@oncodaily.com
SUMMARY:ESMO Immuno-Oncology Congress 2025
DESCRIPTION:The ESMO Immuno-Oncology Congress 2025 will be held from 10 to 12 December 2025 as a hybrid event\, both onsite in London\, UK\, and online. This leading international congress brings together experts from around the globe to explore the full spectrum of immuno-oncology from basic science and translational research to clinical advancements. Attendees can expect cutting-edge sessions\, in-depth learning opportunities\, and dynamic networking with peers\, researchers\, and industry leaders. \nThe programme includes immersion sessions focused on immunobiology and translational insights\, updates on checkpoint inhibitor-based therapies\, and the latest in immune modulation including tumour microenvironment\, immunometabolism\, and cell signaling. Participants will also engage with industry and independent investigators to explore developments in cellular therapies\, cancer vaccines\, intratumoural immunotherapy\, and multispecific constructs. \nWhether attending in person or online\, the congress offers a valuable platform to share research\, expand knowledge\, and shape the future of cancer immunotherapy. \nRegistration is Open for the Event. \nMore posts featuring ESMO.
URL:https://oncodaily.com/event/esmo-immuno-oncology-congress-2025-321830
LOCATION:Queen Elizabeth II Centre in London\, United Kingdom\, Broad Sanctuary\, London SW1P 3EE\, London\, United Kingdom
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_6227.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251210
DTEND;VALUE=DATE:20251211
DTSTAMP:20260405T091654
CREATED:20251123T193232Z
LAST-MODIFIED:20251123T193250Z
UID:10000395-1765324800-1765411199@oncodaily.com
SUMMARY:ESMO Virtual Journal Club: December 2025
DESCRIPTION:The ESMO Virtual Journal Club: December 2025 is a one-hour virtual educational event exclusively for ESMO Members\, scheduled for Wednesday\, December 10\, 2025\, at 18:30 CET. \nChaired by Dr. Anna Campbell\, the Journal Club aims to enhance the understanding and application of the latest research in oncology by focusing on and critically evaluating two newly published studies: “Structured Exercise after Adjuvant Chemotherapy in Colon Cancer (CHALLENGE)” and “Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer.” Live attendees will receive a certificate of attendance and 1 ESMO-MORA category 1 point. \nRegister.
URL:https://oncodaily.com/event/esmo-virtual-journal-club-415070
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/11/ESMO-1-1.png
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251208
DTEND;VALUE=DATE:20251210
DTSTAMP:20260405T091654
CREATED:20251130T151257Z
LAST-MODIFIED:20251130T151257Z
UID:10000426-1765152000-1765324799@oncodaily.com
SUMMARY:ESMO Preceptorship on NSCLC and SCLC 2025: Singapore
DESCRIPTION:The ESMO Preceptorship on NSCLC and SCLC 2025 in Singapore\, taking place from 8 December 2025 to 9 December 2025\, brings together oncology professionals to explore best practices in managing non-small-cell and small-cell lung cancer across all stages. \nThe programme covers the latest in targeted therapies\, actionable driver alterations\, immune checkpoint blockade\, novel immunotherapies\, and systemic treatment of SCLC and pleural mesothelioma. Accredited with 10 ESMO-MORA category 1 points\, the preceptorship offers participants hands-on learning\, expert insights\, and a travel grant for non-local attendees to support participation.
URL:https://oncodaily.com/event/418939
LOCATION:The Orchard Singapore Hotel\, 442 Orchard Road\, Singapore\, 238879\, Singapore
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/BeFunky-collage-2025-11-30T191149031-Picsart-AiImageEnhancer.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20251205T080000
DTEND;TZID=America/Halifax:20251207T170000
DTSTAMP:20260405T091654
CREATED:20250624T132413Z
LAST-MODIFIED:20250624T132433Z
UID:10000204-1764921600-1765126800@oncodaily.com
SUMMARY:ESMO Asia Congress 2025
DESCRIPTION:ESMO Asia Congress 2025 will be held from December 5-7\, 2025 at Singapore\, Republic of Singapore. \nThe congress serves as a vital platform to advance cancer care through the latest scientific discoveries\, innovative therapies\, and evolving clinical practices. Whether you’re a clinician\, researcher\, or healthcare provider\, this gathering offers a front-row seat to the future of oncology. \nCongress Officers for ESMO Asia Congress 2025 are Fabrice André\, Do-Youn Oh\, Sjoukje Oosting\, Arun Azad\, and Nadia Harbeck. \nAttendees can expect a rich and diverse programme featuring plenary lectures\, multidisciplinary tumour boards\, “Meet the Expert” sessions\, and poster presentations\, all designed to promote cross-disciplinary learning and collaboration. With a strong emphasis on clinical excellence and global perspectives\, ESMO Asia fosters a vibrant exchange of knowledge\, helping to shape cancer treatment strategies tailored to the region’s unique challenges. \nMark your calendar for this transformative event in Singapore\, where science meets practice to improve patient outcomes. \nRegistration is Open for The Event. \n 
URL:https://oncodaily.com/event/esmo-asia-congress-2025-317714
LOCATION:Suntec Singapore Convention & Exhibition Centre\, 1 Raffles Boulevard Singapore\, Singapore\, 039593\, Singapore
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/06/download-7-Picsart-AiImageEnhancer-1.png
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251203
DTEND;VALUE=DATE:20251205
DTSTAMP:20260405T091654
CREATED:20251122T003001Z
LAST-MODIFIED:20251122T003025Z
UID:10000388-1764720000-1764892799@oncodaily.com
SUMMARY:ESMO Preceptorship on Breast Cancer 2025: Singapore
DESCRIPTION:The ESMO Preceptorship on Breast Cancer 2025: Singapore is a two-day educational event focused on various aspects of breast cancer management\, co-chaired by Rebecca Dent and Matteo Lambertini. \nScheduled for December 3–4\, 2025\, in Singapore\, Republic of Singapore\, the program aims to provide comprehensive learning on screening\, diagnosis\, genetic testing\, the biology of the disease\, and the crucial role of multidisciplinary care in managing early\, locally advanced\, and metastatic breast cancer across surgical\, radiation\, and systemic therapy settings. The course is accredited with 10 ESMO-MORA category 1 points
URL:https://oncodaily.com/event/preceptorship-on-breast-cancer-414103
LOCATION:Singapore\, Republic of Singapore
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/11/16_9.png
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251203
DTEND;VALUE=DATE:20251205
DTSTAMP:20260405T091654
CREATED:20251122T002130Z
LAST-MODIFIED:20251122T002146Z
UID:10000387-1764720000-1764892799@oncodaily.com
SUMMARY:ESMO Preceptorship on Gastric Cancer 2025: Singapore
DESCRIPTION:The ESMO Preceptorship on Gastric Cancer 2025: Singapore is an intensive two-day educational event focused on the multidisciplinary management of gastric and gastro-esophageal junction (GEJ) cancers. \nScheduled for December 3–4\, 2025\, in Singapore\, Republic of Singapore\, the program is designed to cover topics ranging from the fundamentals of epidemiology and molecular factors to best clinical practices in surgical\, adjuvant\, and metastatic settings. The course aims to teach participants to compare various approaches\, manage special situations and side effects\, and learn about novel treatment targets. This event is accredited with 9 ESMO-MORA category 1 points.
URL:https://oncodaily.com/event/preceptorship-on-gastric-cancer-414098
LOCATION:Singapore\, Republic of Singapore
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/11/GwEIvRVWcAAI2Ci.png
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251203
DTEND;VALUE=DATE:20251204
DTSTAMP:20260405T091654
CREATED:20251123T185516Z
LAST-MODIFIED:20251123T190312Z
UID:10000393-1764720000-1764806399@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases - Webinar Series: Prostate Cancer 2025
DESCRIPTION:The ESMO Guidelines: Real World Cases – Prostate Cancer 2025 is a one-hour live virtual webinar held by the European Society for Medical Oncology (ESMO) on December 3\, 2025\, at 18:30 CET. Its goal is to disseminate and critically review the updated ESMO Clinical Practice Guidelines for prostate cancer by applying them to a detailed\, real-world clinical case\, focusing on optimal treatment sequencing and the integration of novel therapies. \nThe session is targeted at all healthcare professionals working in Oncology\, and live viewers will be awarded a certificate of attendance and 1 ESMO-MORA category 1 point. \nRegister.
URL:https://oncodaily.com/event/esmo-guidelines-415049
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/esmo.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251129
DTEND;VALUE=DATE:20251130
DTSTAMP:20260405T091654
CREATED:20251122T001546Z
LAST-MODIFIED:20251122T001558Z
UID:10000386-1764374400-1764460799@oncodaily.com
SUMMARY:Best of ESMO 2025 Breast Cancer China Session
DESCRIPTION:The Best of ESMO 2025 Breast Cancer China Session is an ESMO Licensed Event scheduled as a virtual session on November 29\, 2025\, at 12:00 CET. \nThis event is designed to efficiently disseminate the most practice-changing and relevant scientific findings in breast cancer from the main ESMO Congress 2025 to healthcare professionals in the region. The content is accessible online and is presented in both Chinese (Traditional) and English.
URL:https://oncodaily.com/event/esmo-2025-414095
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/11/Screenshot-2025-11-22-041309.png
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251128
DTEND;VALUE=DATE:20251130
DTSTAMP:20260405T091654
CREATED:20251122T001117Z
LAST-MODIFIED:20251122T001131Z
UID:10000385-1764288000-1764460799@oncodaily.com
SUMMARY:ESMO Advanced Course on ADC Development\, Therapeutic Applications and Research in GI and Gynaecological Cancers 2025: Zurich
DESCRIPTION:The ESMO Advanced Course on ADC Development\, Therapeutic Applications and Research in Gastrointestinal and Gynaecological Cancers 2025: Zurich is a two-day educational event organized by ESMO (European Society for Medical Oncology). \nScheduled for November 28–29\, 2025\, in Zurich\, Switzerland\, the course is focused on providing in-depth insights into Antibody-Drug Conjugates (ADCs)\, including their development\, mechanism of action\, integration into current clinical guidelines\, and management of associated toxicities. The program is accredited with 10 ESMO-MORA category 1 points for Continuing Medical Education.
URL:https://oncodaily.com/event/esmo-advanced-course-414092
LOCATION:Dorint Airport-Hotel Zurich\, Riethofstrasse 40\,\, 8152 Opfikon\, Zurich
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/11/ESMO-1.png
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251127
DTEND;VALUE=DATE:20251129
DTSTAMP:20260405T091654
CREATED:20251122T000459Z
LAST-MODIFIED:20251122T000544Z
UID:10000384-1764201600-1764374399@oncodaily.com
SUMMARY:UpToDate 6.0 + ESMO
DESCRIPTION:The UpToDate 6.0 + ESMO conference\, organized by the Ukrainian Society of Clinical Oncologists (USCO) in partnership with ESMO\, is a two-day event scheduled for November 27–28\, 2025. \nThis major oncology conference will be held in Kyiv\, Ukraine\, at the Ramada Encore Kyiv. The primary goal is to bring together a multidisciplinary community of experts—including medical oncologists\, surgeons\, and pathologists—for the sixth consecutive year to share the latest and most innovative ideas in cancer diagnosis and treatment\, with all participants receiving Continuing Medical Education (CME) points. \nRegister.
URL:https://oncodaily.com/event/uptodate-414086
LOCATION:Ramada Encore by Wyndham Kyiv\, 103\, Stolychne Highway\, Kyiv\, Kyiv Oblast\, 03131\, Ukraine
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/11/OncoDaily-Stuff-.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251126
DTEND;VALUE=DATE:20251127
DTSTAMP:20260405T091654
CREATED:20251120T204130Z
LAST-MODIFIED:20251120T204130Z
UID:10000383-1764115200-1764201599@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases - Webinar Series: Lymphoma 2025
DESCRIPTION:The ESMO Guidelines: Real World Cases – Webinar Series: Lymphoma 2025 will be held live on 26 November 2025 at 18:30 CET. \nThis webinar applies the latest ESMO Clinical Practice Guidelines to real-world lymphoma cases. Participants will gain insights into evidence-based management\, innovative therapies\, and practical strategies for Hodgkin and non-Hodgkin lymphomas\, earning 1 ESMO-MORA category 1 point and a certificate of attendance.
URL:https://oncodaily.com/event/413052
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/BeFunky-collage-95-Picsart-AiImageEnhancer.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:https://oncodaily.com/event/413052
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251121
DTEND;VALUE=DATE:20251123
DTSTAMP:20260405T091654
CREATED:20251120T204713Z
LAST-MODIFIED:20251120T204727Z
UID:10000380-1763683200-1763855999@oncodaily.com
SUMMARY:ESMO Advanced Course on Cholangiocarcinoma 2025: Barcelona
DESCRIPTION:The ESMO Advanced Course on Cholangiocarcinoma 2025 will be held on 21–22 November 2025 at the Hotel Barcelona Center in Barcelona\, Spain. \nThis course provides a comprehensive update on the diagnosis\, molecular profiling\, and management of cholangiocarcinoma\, covering surgery\, locoregional therapies\, immunotherapy\, targeted treatments\, and both adjuvant and palliative strategies. Accredited with 11 ESMO-MORA points\, the program is designed to enhance the knowledge and clinical skills of medical oncologists managing this challenging malignancy.
URL:https://oncodaily.com/event/esmo-advanced-course-413002
LOCATION:Hotel Barcelona Center\, Carrer de Balmes\, 103‑105\, Eixample\, Barcelona\, 08008\, Spain
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/BeFunky-collage-92-Picsart-AiImageEnhancer.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251121
DTEND;VALUE=DATE:20251123
DTSTAMP:20260405T091654
CREATED:20251120T204356Z
LAST-MODIFIED:20251120T204408Z
UID:10000382-1763683200-1763855999@oncodaily.com
SUMMARY:ESMO Advanced Course on ADC Development\, Therapeutic Applications and Research in Breast Cancer 2025: Barcelona
DESCRIPTION:The ESMO Advanced Course on ADC Development\, Therapeutic Applications and Research in Breast Cancer 2025 will be held on 21–22 November 2025 in Barcelona\, Spain. \nThis course\, chaired by Prof. Javier Cortés and Prof. Nadia Harbeck\, provides an in-depth exploration of antibody-drug conjugates (ADCs)\, covering drug development\, mechanisms of action\, integration into clinical practice\, and management of associated toxicities. Accredited with 9 ESMO-MORA category 1 points\, it offers participants a comprehensive platform to advance their knowledge and expertise in breast cancer therapeutics.
URL:https://oncodaily.com/event/esmo-advanced-course-413037
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/BeFunky-collage-94-Picsart-AiImageEnhancer.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251113
DTEND;VALUE=DATE:20251117
DTSTAMP:20260405T091654
CREATED:20251102T221849Z
LAST-MODIFIED:20251102T222006Z
UID:10000310-1762992000-1763337599@oncodaily.com
SUMMARY:17th European Multidisciplinary Congress on Urological Cancers
DESCRIPTION:The 17th European Multidisciplinary Congress on Urological Cancers (EMUC 2025) is a highly specialized event organized by the European Society for Medical Oncology (ESMO). This congress is focused entirely on urological cancers\, bringing together top experts from various fields including medical oncology\, pathology\, radiation oncology\, and urology to discuss best practices\, major trial developments\, and breakthroughs. Scheduled to take place in Prague\, Czech Republic\, from 13 to 16 November 2025\, the event emphasizes essential updates\, popular hands-on training courses\, and eye-opening multidisciplinary case discussions to advance treatment and care for genitourinary (GU) cancers. \nYou can find more posts featuring EMUC25 on OncoDaily.
URL:https://oncodaily.com/event/urological-cancers-402235
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/11/EMUC25-Social-media-image.png
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20251112T080000
DTEND;TZID=Europe/Berlin:20251114T170000
DTSTAMP:20260405T091654
CREATED:20250710T164637Z
LAST-MODIFIED:20250710T164721Z
UID:10000208-1762934400-1763139600@oncodaily.com
SUMMARY:The ESMO AI and Digital Oncology Congress 2025
DESCRIPTION:The ESMO AI and Digital Oncology Congress 2025 will be held from 12–14 November in Berlin\, Germany. \nThis event offers a dynamic platform for exploring the intersection of artificial intelligence\, digital technologies\, and oncology. With a focus on the latest research\, ethical considerations\, and technological innovations\, the congress brings together clinicians\, researchers\, technologists\, and healthcare leaders to discuss how digital tools are reshaping cancer care. \nDesigned to foster collaboration across disciplines\, the congress provides valuable insights into how AI and digital health solutions can enhance diagnosis\, treatment\, and patient outcomes. It’s an essential event for cancer care professionals aiming to stay ahead in the digital transformation of oncology. \nRegistration is Open for the Event.
URL:https://oncodaily.com/event/esmo-326991
LOCATION:Messe Berlin\, Messedamm 22\, Berlin\, 14055\, Germany
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_6679.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251107
DTEND;VALUE=DATE:20251109
DTSTAMP:20260405T091654
CREATED:20251028T222847Z
LAST-MODIFIED:20251028T222858Z
UID:10000298-1762473600-1762646399@oncodaily.com
SUMMARY:ESMO Advanced Course on Pancreatic Cancer
DESCRIPTION:The ESMO Advanced Course on Pancreatic Cancer: From Standard Treatment to Individualization 2025 is a specialized two-day event scheduled to take place in Zurich\, Switzerland\, from November 7–8\, 2025. The course is designed to provide oncology professionals with an updated\, interdisciplinary overview of managing pancreatic cancer. A core goal is to move beyond generalized standards of care by interactively discussing treatment strategies based on patient cases\, study data\, and the latest ESMO Clinical Practice Guidelines. The course will challenge attendees to “think outside the box” regarding current and future individualized therapy strategies. \nThe program aims to address the most critical issues in an interdisciplinary way\, ensuring participants can apply the information to individual clinical decision-making immediately upon returning to their practice. While the application deadline has closed\, confirming the participant list is finalized\, the course remains accredited with 9 ESMO-MORA category 1 points for medical oncologists seeking recertification. Non-local participants will be eligible for a travel grant of up to 600 euros to assist with their travel costs to the Zurich venue. \nYou can find more posts featuring ESMO on OncoDaily.
URL:https://oncodaily.com/event/esmo-399792
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/10/esmo-2.png
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20251031T120000
DTEND;TZID=America/Halifax:20251031T213000
DTSTAMP:20260405T091654
CREATED:20251027T225514Z
LAST-MODIFIED:20251027T225531Z
UID:10000293-1761912000-1761946200@oncodaily.com
SUMMARY:6th ESMO in the Alps
DESCRIPTION:The 6th ESMO in the Alps is a one-day oncology conference\, licensed by the European Society for Medical Oncology (ESMO)\, scheduled for October 31\, 2025\, at the KKL Luzern (Kultur- und Kongresszentrum Luzern) in Lucerne\, Switzerland. This event is designed to bring the highlights and practice-changing studies presented at the major ESMO Congress 2025 directly to the Swiss medical community. \nIt is held under the auspices of the CPTC network of the Swiss Cancer Institute and offers Continuing Medical Education (CME) credits for physicians and specialists in various fields\, focusing on providing a comprehensive\, post-congress review. \nThe conference program is structured around five crucial areas of oncology: GI Cancer\, GU Cancer\, Breast/Gyn Cancer\, Lung Cancer\, and Hot Topics. The format includes presentations of original videos from the ESMO Congress\, followed by interactive live discussions led by local Swiss experts and original study authors. \nYou can find more posts featuring ESMO on OncoDaily.
URL:https://oncodaily.com/event/esmo-in-the-alps-399387
LOCATION:KKL Luzern\, Europapl. 1\, 6005 Luzern\, Switzerland\, Lucerne (Luzern)\, Canton of Lucerne\, 6005\, Switzerland
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/10/Screenshot-2025-10-28-025422.png
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20251017T100000
DTEND;TZID=Europe/Berlin:20251021T130000
DTSTAMP:20260405T091654
CREATED:20250207T184059Z
LAST-MODIFIED:20250607T192601Z
UID:10000133-1760695200-1761051600@oncodaily.com
SUMMARY:ESMO 2025 Congress
DESCRIPTION:The ESMO 2025 Congress is a premier global oncology event\, bringing together clinicians\, researchers\, patient advocates\, journalists\, and healthcare industry professionals from around the world. ESMO 2025\, held in Berlin from October 17-21\, will showcase groundbreaking discoveries\, cutting-edge treatments\, and a collaborative approach to shaping the future of cancer care. \nAt ESMO 2025\, participants will have the opportunity to learn from internationally renowned experts\, engage in insightful discussions\, and connect with oncology professionals advancing the fields of diagnosis\, treatment\, and survivorship. The event will cover key topics such as cancer prevention\, screening\, early diagnosis\, and the latest breakthroughs in cancer research\, offering valuable insights into the clinical applications of scientific advances in cancer biology\, diagnostics\, and treatments. \nRegistration is open for the event.
URL:https://oncodaily.com/event/240197
LOCATION:Messe Berlin\, Messedamm 22\, Berlin\, 14055\, Germany
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/02/2025_ESMO_inevidenza-e1738953034978.png
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
END:VCALENDAR